Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The longtime broadcast partner may soon be losing out on live games, but Warner Bros. Discovery won’t be completely sidelined by the NBA.
Snacking conglomerates all agree: Petcare mergers and acquisitions are the cat’s pajamas. Just ask General Mills.
Has Bob Iger now done it? Has he restored the magic, the thing defeated activist agitator Carl Icahn said was missing?
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
The company’s recent patent signals that AI is coming both for the world of advertising and entertainment at large.
Honeywell may just be the next conglomerate to split into various pieces. At least if Elliott Investment Management has its way.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Shell managed to overturn a Dutch legal order made in 2021 that had mandated the company cut its emissions 45% from 2019 levels by 2030.
Nestlé and Formula 1 announced on Monday that starting with the upcoming 2025 season KitKat will be the sport’s “official chocolate bar.”
Dissapointing results for two mid-stage trials strikes a blow in Abbvie’s expensive pipeline-via-M&A strategy.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.